Plasma CellsMultiple MyelomaParaproteinemiasTransplantation, AutologousBone MarrowBone Marrow CellsHematopoietic Stem Cell TransplantationStem Cell TransplantationPrognosisPeripheral Blood Stem Cell TransplantationTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsMelphalanBone Marrow TransplantationFlow CytometryTransplantation ConditioningAmyloidosisCombined Modality TherapyParaproteinsB-LymphocytesTreatment OutcomeStem CellsRemission InductionSalvage TherapyDisease-Free SurvivalCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinBone Marrow PurgingRecurrenceCytarabineGraft vs Host DiseaseMyeloablative AgonistsHematopoietic Stem CellsHematopoietic Stem Cell MobilizationCarmustineSurvival RateThiotepaVincristineLeukemia, Plasma CellWhole-Body IrradiationHematologic NeoplasmsSurvival AnalysisLymphoma, Mantle-CellRetrospective StudiesBusulfanBone and BonesDoxorubicinGraft SurvivalBoronic AcidsAntigens, CD34Mesenchymal Stem Cell TransplantationDexamethasonePyrazinesTime FactorsFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularAntineoplastic Agents, AlkylatingGranulocyte Colony-Stimulating FactorAntineoplastic AgentsAutograftsThalidomideLymphoma, T-Cell, PeripheralLiver TransplantationCell- and Tissue-Based TherapyCell DifferentiationLymphomaIfosfamideCell TransplantationTransplantation ChimeraPrednisoneInduction ChemotherapyLeukapheresisLeukemia, Myeloid, AcuteNeoplasm, ResidualPodophyllotoxinTissue DonorsLymphoma, Large B-Cell, DiffuseCord Blood Stem Cell TransplantationEmbryonic Stem CellsMyelodysplastic SyndromesHematopoiesisMaintenance ChemotherapyMesenchymal Stromal CellsLymphoma, B-CellAdult Stem CellsAntibodies, MonoclonalCells, CulturedKidney TransplantationBone Marrow DiseasesLeukemiaMitoxantroneProspective StudiesIdarubicinImmunosuppressive AgentsEnteropathy-Associated T-Cell LymphomaHistocompatibility TestingLeukemia, Myeloid